Web Site : http://www.iofina.com/

11th April 2008 Note on IOF : Link to web folder click here

Iofina is the holding company of a group of companies involved in the exploration and production of iodine and natural gas which have been discovered on acreages which the Group acquired, or is currently acquiring, in the state of Montana, USA. The Company has named its discovery the Atlantis Prospect. The natural gas co-exists with formation water containing relatively high levels of dissolved iodide. Iodine is a rare element, which the US currently imports to meet growing domestic demand from pharmaceutical and industrial manufacturers. The leases held by the Group give it the right to explore, drill and produce both iodine and natural gas. The Directors believe that the dual revenue streams of iodine and gas, together with the relatively low cost extraction process, will create an attractive business model with substantial strategic value.

Iofina was incorporated on 15 March 2005 in the UK and registered in England and Wales. In January 2006 the Group acquired the entire issued share capital of Iofina Inc. and its wholly owned subsidiary Iofina Natural Gas Inc., each of which is a Colorado corporation, with the objective of becoming a low cost producer of iodine and natural gas. Iofina Chemical Inc., a Colorado corporation, was created as the specialty chemical division of Iofina Inc. in May 2006. The Groups Atlantis Prospect is located between two of the most significant biogenic gas fields in North America, which have so far produced a total of 6.5 Tcf, valued at over US$50 billion at current prices. Since its incorporation the Group has steadily acquired over 30,000 net acre land position in northern Montana, on which a major aquifer containing natural gas has been discovered in the Eagle and Virgelle formations, sedimentary formations of Cretaceous age lying at depths of 1,000 to 1,500 ft below the surface. This unconventional, shallow natural gas resource can only be produced in conjunction with large volumes of formation water, and consequently the industry has previously struggled to commercialise gas discoveries in the area. The formation water is an unusual sodium chloride brine with high concentrations of iodide but relatively low levels of dissolved salts (approximately 6,500 mg/L), and has no contaminants or hydrocarbons other than methane, thereby reducing processing costs. Iofina intends to produce gas along with water, but to also extract the high levels of iodine which the formation water contains.

In addition to its acreage position, the Group currently owns four pilot wells, an iodine processing facility building and the Iofina Express #1 pipeline which ultimately connects into the TransCanada Pipeline, a major transcontinental gas pipeline serving markets in the north-eastern United States.

Comments at proactive investor

proactive investor / atlantis helps raise iofina

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)



Board Changes



The Board of Iofina has accepted, with regret, the resignation from the Board, on health grounds, of Lance Baller the Group CEO and Company Secretary. As a result, the resolution to re-elect him as a Director of the Group will be withdrawn from the agenda at the Annual General Meeting ("AGM") to be held on 19 June 2013. Mr Baller has been retained as a consultant to the Group with effect from the AGM.


Efforts to recruit a new CEO, who would be joining the group at a very exciting time in the rapid development of the company, are being pursued immediately. Chris Fay will continue to act as Executive Chairman of the Group and, effective from the AGM, Stuart Eaton will revert to his Non-Executive role on the Board. In addition, Mr Simon Holden has been appointed as Company Secretary effective at the conclusion of the AGM.


Commenting on the resignation Chris Fay, Executive Chairman said:



"Lance's efforts, firstly as finance director and latterly as CEO, have been instrumental in the development of the group, not least the realisation of its production activities to the current status of two producing plants and the imminent roll out of many more. His commitment has been of the highest order throughout his tenure. The board is pleased to have secured his services on an on-going basis as a consultant to the group.

"The board extends its sincere best wishes to him and his family in the hope he will soon return to full health."

SP down 26%?

Lots of speculation, but this seems to cover most of the problems:
http://share-knowledge.org.uk/2013/06/23/is-iofina-vulnerable/

A day to buy earlier on, some did

and now is almost 10p higher from the lows of the day

10.50p higher at 178.50p

Bed and breakfast, badly done by the spread

Director's Dealings

Iofina, specialists in the exploration and production of iodine, with vertical integration into specialty chemical iodine derivatives, was informed on 4 July 2013 that on the same day, Stuart Eaton, a Non-Executive Director of the Company, sold 26,500 ordinary shares of 1 penny each ("Ordinary Shares") at an average price of 166 pence per share. Immediately following such sale, Mr Eaton's personal SIPP purchased 26,500 Ordinary Shares at an average price of 172.8 pence per share.

For the avoidance of doubt Mr Eaton's holding in the Company has not changed and he continues to be interested in 1,349,761 Ordinary Shares representing 1.06 per cent. of the Company's issued share capital.

Some good move up this morning after loosing almost all the early gains yesterday


'Iodine ingestion can help fight breast cancer'

http://atlantablackstar.com/2013/07/04/natural-healing-iodine-can-help-cure-breast-cancer/

Well on the way up with 10p higher after bullish comment on the figures

Interim Results 2013
Strongest First Half in Group histor

Iofina, specialists in the exploration and production of iodine, with complete vertical integration into specialty chemical iodine derivatives, is pleased to announce Interim Results for the six months ended 30 June 2013 a period which has seen a continuation of the execution of Iofina's expansion strategy.

The Board expect to complete construction of IO#3, IO#4, IO#5 and IO#6 by year end. With these plants fully operational, it is estimated that the annualised production rate will be between c.700-c.1000 metric tonnes of crystallized iodine which would see Iofina become one of the lowest cost and largest iodine producers in North America, enabled by its patent protected WET® IOsorb™ technology.

FINANCIAL HIGHLIGHTS:
· Strongest first half in Group history;

· Second consecutive period of positive EBITDA;

· Record H1 Revenue of $11,556,468 (H1 2012: $7,667,162), a 51% increase in revenues;

· Like-for-like losses of $124,410, nearly breakeven per share (H1 2012: net loss of $969,935 or ($0.01/share);

· Improved cash balance at 30 June 2013 of $16,189,567 (30 June 2012: $10,388,096);

· Successful Convertible Bond Issue of $15,000,000 in May 2013; and

· Strong outlook for H2 revenues and profits from Iofina Resources as production from existing plants and four new plants come on line.

OPERATIONAL HIGHLIGHTS:

· Strong Management and expanded Operations team in place to deliver growth, including the recent appointments of George Lantz and Gary Gatchell as CEO and FD, respectively;

· Record revenues for the Group through continued strong performance of Iofina Chemical processing both recycled iodine as well as increasingly the Group's own iodine production from Iofina Resources;

· Multiple site contract won with one of the largest oil and gas operators in the US;

· Identification of six (6) additional highly promising iodine rich sites for the 2014 expansion strategy; and

· Detailed engineering report completed and Montana permit application on the non-core Atlantis Water Project has been lodged.

Commenting on the Results, Dr. Chris Fay, Non-Executive Chairman, stated:

''Iofina is now in an excellent position to monetise its proven technology with a total of six IOsorb™ plants in production by the end of 2013 and a further six planned for 2014. Process optimisation at IO#1 and IO#2 continues to produce higher iodine yields and this knowledge and experience will be applied to future plants. The key IOsorb™ patent was issued in Q2 2013, protecting our significant competitive intellectual property. The recruitment of George Lantz and Gary Gatchell as CEO and FD respectively, has added significant experience and leadership to the management team as we now enter what should be a highly exciting period for Iofina shareholders marked by rapid growth as our roll out strategy unfolds."

A higher BREAKOUT as is moving up with the good news

High of 184.25p earlier on, and as usual profit taking since, is holding around the 175p price now, much the same of late this morning at 172 to 178p for a while till it broke up

Not sure what to make of Iofina at the moment.

I have it on my watch list, tempted to get back in, but looking for an entry point.

They are behind on the latest IOsorb plant and new CEO and FD.

Winter on the way which caused a few problems last year.

Taken from ADVN SHARE TIPS FROM INVESTORS CHRONICLE Iofina PLC Thu 03 October 2013 A A A Recommendation type: Speculative Matthew Allan Every once in a while, a game-changing technology comes along that has the potential to revolutionise a market along with the fortunes of the company responsible for developing it. That's exactly the opportunity Iofina (IOF) has: a patented, highly profitable technology to extract iodine from waste water associated with shale oil and gasfields in the US. Iodine has a vast range of uses, ranging from speciality electronics to animal health products and disinfectants, but is conventionally expensive to produce. It currently sells for around $50 a kilogramme, yet Iofina's IOsorb plants can produce it for as little as $10-$20 a kilogramme - about half the cost incurred by competitors mining iodine in Chile. The company has built two plants so far. It has one small trial plant in Texas and a larger, commercial-grade plant in Oklahoma that was commissioned in January 2013. Between them, Iofina made impressive gross profits of $2.5m (�1.6m) in the six months to 30 June 2013 on record revenues of $11.6m. But most importantly Iofina proved that its technology really works. Granted, both plants experienced some initial teething problems. Iofina could not find a reliable enough supply of waste water at the first plant and water had to be trucked in. The second plant is faring much better, though, as it receives waste water directly via pipeline from oil-producing wells owned by a single supplier. This gives greater certainty of supply as well as higher water temperatures, which increase plant efficiency. This will be the model going forward. Unfortunately, a "highly improbable" event occurred in June whereby produced oil was not separated from the waste water. This temporarily hindered the plant's operations, but Iofina's equipment is now back to normal. On the positive side, this demonstrated that the plant is robust enough to withstand a large shock of oil. With new design improvements incorporated, Iofina plans to rapidly ramp up development and roll out dozens of plants across the US. A third plant is on track to be completed by the end of September 2013 and three more are under construction and are expected to be installed by the year-end. A further six plants are expected in 2014. Analysts from Investec estimate each plant adds $20m (10p per share) of value versus a capital cost of just $2-3m.

article on iof

100p support.

96p low of the day, since higher with the little movement down as the order book takes the bid price

Market makes did not like the jam tomorrow outlook 2014


2013 Review and 2014 Outlook

Commenting on today's news, CEO George Lantz, said: "Whilst we expect revenues and EBITDA to be comparable to 2012, 2013 has seen the successful deployment of Iofina's IOsorb technology along with the continued growth of its derivatives business. Taking stock of the iodine production opportunities, increased derivative sales and prilling that are open to Iofina, 2014 signifies an exciting year for the rapidly expanding Group."

Director Dealing

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, were informed today that Chris Fay, Non-Executive Chairman of the Group has today purchased 50,000 ordinary shares at an average price of 101p. Mr Fay now holds 1,300,000 ordinary shares in the Company, representing 1.02 per cent of the Company's issued share capital.

We initiate on Iofina with a Buy recommendation and 156p/share target price. With Iofina's shares trading at recently depressed levels, we
believe this represents an excellent entry point to a business with a unique business model and significant growth potential. In our view the
market has taken an overly cautious view on plant roll-out, iodine price and/or cash margins. Despite a softening of global iodine spot prices,
Iofina's unique business model remains robust and looks to deliver peer-leading returns. We expect to see a re-rating towards our target price
as Iofina delivers on 2014 production and cash flow expectations. Furthermore, we see significant valuation upside (35-45p/share) in the event
Iofina installs a prilling plant, a process that turns crystalline iodine in to pellets, increasing the realised price Iofina can receive for external
sales. With six operational plants in 2014 and a further three under consideration, we expect revenues to grow from $18.8m FY13 to $39.9m
FY14 and $60.4m in FY15. Whilst global supply additions should keep pace with growing global demand, we expect the market to remain well
balanced in the medium term, with a price floor in the mid-40‟s supported by the relatively high cash cost associated with Chilean mined iodine.
Iofina‟s operational costs, including a royalty paid to the upstream operator, are estimated to be $21/kg, compared to Chilean iodine mining
cash operating costs of closer to $35-45/kg. High operational margins support out forecasts of significant near-term free cash flow generation.

Re Buy recommendation. Where did you find this Cyril?

Well i;ve just bought in this am,it's a producer of a wanted product.In the middle of an expansion program,which should yeild a healthy return medium turn.
----------------------------------------------------------------------------------

">

at a crucial point -